Using AI and Big Data to Revolutionize Pharmaceutical R&D

Using AI and Big Data to Revolutionize Pharmaceutical R&D

In the world of Life Sciences, AI and big data have emerged as crucial tools in revolutionizing pharmaceutical R&D. Anne Dhulesia, a Partner in L.E.K.’s European Life Sciences practice, explains how these technologies can optimize the drug development process and ultimately improve patient outcomes.

The pharmaceutical industry invests significant resources in R&D, with the top 10 pharma companies spending up to US$15bn per year. Leveraging the power of data, including AI, allows these companies to optimize the deployment of their R&D capital and expedite the delivery of novel medicines to patients.

AI and big data have been integrated into various stages of the pharmaceutical R&D process. For example, AI tools can analyze academic scientific publications to discover new biological pathways and potential drug targets. Databases can be interrogated to identify new applications for existing drugs, as demonstrated during the COVID-19 pandemic. Additionally, AI algorithms can help select the right patients for specific therapies based on biomarkers, leading to more precise and powerful treatments.

L.E.K. assists investors and corporates in understanding the potential of AI and big data in the life sciences space. They help investors identify trends and differentiate between players in the field, while also guiding corporates in implementing these technologies within their organization and managing the necessary change.

Looking ahead, the industry is only scratching the surface of what AI and big data can bring to pharmaceutical R&D. Over the next 12 months, the industry will showcase how these technologies can accelerate specific steps in the R&D value chain, demonstrating their potential to revolutionize drug discovery and development. Partnerships between AI and big data companies and biopharma players will continue to grow, further validating the industry’s interest in leveraging data. These advancements will solidify AI and big data as essential components of any pharmaceutical R&D process.

Source: Healthcare Digital

All Rights Reserved 2021.
| .